Latest News
-
SAN DIEGO – Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that a multiyear research grant from Luxembourg National Research Fund (FNR) and Cancer Foundation Luxembourg has been awarded to Doctor Anna Golebiewska Ph.D., co-leading... -
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C. – Kriya Therapeutics, Inc., a fully integrated company pioneering novel technologies and therapeutics in gene therapy, announced today that it has acquired Warden Bio, a company developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). Under the agreement, Kriya has obtained...
-
SAN FRANCISCO – Real Chemistry, a leading provider of data-driven, tech-enabled communication and marketing solutions for the health care sector, announced that it is now a Veeva Global Content Partner. Veeva Systems is the global leader in cloud software for the life sciences industry, including the majority of Real Chemistry’s...
Videos
Rare disease spotlight
& not medically necessary
Medical best practice is you diagnose based on symptoms, and confirm with a test
No symptoms, no test
This is just child abuse
Come on @AmerAcadPeds @ESPO_PedENT @who Start defending children based on medicine & science & stop your political silence
This is not normal. It is completely abnormal. https://twitter.com/prof_freedom/status/1482019804177391625
#RareDiseaseDay2018
My little sister has a rare chromosome disorder called @Phelan_McDermid. She is #1in5million and today is about raising awareness for people like her #worldwide!
Please share and continue to raise awareness for people like my sister!❤️☘️
To send 4 tests costs $8B+. That is 8x the amount the US spends on #raredisease research for 7000+ diseases A YEAR
Each policy you have advocated for ensures more children die of more serious diseases & are harmed from other problems
#Tests & #masks wont stop #SARSCoV2
I commend the Biden administration for their plan to mail tests directly to people in their homes. This is far better than a complex insurance reimbursement system. But 4 tests per family isn’t nearly enough. There needs to be an overall goal for tests to all who want them.
Must Read—Prof @UdiQimron, Head of Immunology/Microbiology at Tel Aviv Univ, pens powerful open letter to 🇮🇱Ministry of Health
“In the end, the truth will always be revealed, & the truth re the coronavirus policy is beginning to be revealed.. 2yrs late..”
https://brownstone.org/articles/ehud-qimrons-powerful-letter-to-the-israeli-ministry-of-health/